HLA antigens in mucocutaneous lymph node syndrome. Pathophysiology, etiology and therapy. The treatment of Kawasaki syndrome with intravenous gamma globulin. TCR V beta family repertoire and T cell activation markers in Kawasaki disease. Medicine is a constantly changing science and not all therapies are clearly established.
New research changes drug and treatment therapies daily.
However, as medical science is constantly changing and human error is always possible , the authors, editors, and publisher or any other party involved with the publication of this article do not warrant the information in this article is accurate or complete, nor are they responsible for omissions or errors in the article or for the results of using this information. The reader should confirm the information in this article from other sources prior to use. In particular, all drug doses, indications, and contraindications should be confirmed in the package insert.